TPQ, TW 

Overview

Feng-lan Chiu practices practicing medicine in Taiwan.

Their clinical expertise encompasses Huntington Disease, Movement Disorders, Dementia, and Zika Virus Disease.

They are actively involved in clinical research, co-authoring 13 peer reviewed articles.

Locations

TPQ 11529, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Frequently Asked Questions about Feng-lan Chiu

Is Feng-lan Chiu a top-rated expert for Huntington Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Feng-lan Chiu is classified as an Experienced expert for Huntington Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Feng-lan Chiu participate in research or clinical trials?

Yes. Feng-lan Chiu has published 13 articles and abstracts on conditions like Huntington Disease. You can view a list of Feng-lan Chiu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chiu's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile